Our research group participated to the Meet in Italy for Life Sciences brokerage event, held from 17 to 19 October 2022. Our contribution is one of the six projects presented by the Università degli Studi di Pavia, and consists in the recently patented invention entitled “substituted vinyl piperazine-piperidine urea derivatives as anticancer agents” (PCT/EP2022/066667).
